Research Overview 
Dr. Copenhaver is an Assistant Professor in the Department of Allied Health Sciences with an emphasis on Health Promotion. His current research involves refining and evaluating behavioral HIV risk reduction interventions that target high risk drug users in community-based treatment settings. He is completing intervention pilot work with opioid-dependent HIV-infected patients for a NIDA-funded K23 career award. He is conducting exploratory work (NIDA-funded R21) that involves adapting and testing an evidence-based HIV risk reduction program for newly-released HIV-infected prisoners in Connecticut. Dr. Copenhaver is also conducting a randomized clinical trial (NIDA-funded R01) of a community-friendly HIV risk reduction intervention for drug users participating in an inner city methadone maintenance program in Connecticut. He has been at the University of Connecticut since 2002.

Education 
Postdoctoral fellow, Yale University, 1999-2000  
Ph.D., Virginia Tech, 1999 (clinical psychology)  
M.S., Villanova University, 1989 (experimental psychology)  
B.A., Clemson University, 1987 (psychology)

Featured Publications 
Norton, W., Amico, R., Fisher, W., Copenhaver, M., Cornman, D. , Friedland, G., Kozal, M., & Fisher, J. (in press 2008). IDU risk behavior and attitudinal correlates in a sample of HIV-infected patients in clinical care. AIDS Patient Care.

Copenhaver, M., Bruce, R., & Altice, F. (2007). Behavioral Counseling Content for Optimizing the Use of Buprenorphine for Opioid Dependence in Community Based Settings: A Review of the Empirical Evidence. American Journal of Drug and Alcohol Abuse, 33, 1-12.

Copenhaver, M., & Lee, I. (2007). Examining the decay of HIV risk reduction outcomes following a community-friendly intervention targeting injection drug users in treatment. Journal of Psychoactive Drugs,39(3).

Copenhaver, M., Lee, I., & Margolin, A. (2007). Successfully integrating HIV risk reduction into a community-based treatment program. American Journal of Drug and Alcohol Abuse, 33(1), 109-120.

Copenhaver, M. & Lee, I. (2006). Optimizing a Community-friendly HIV Risk Reduction Intervention for Injection Drug Users in Treatment: A Structural Equation Modeling (SEM) Approach. Journal of Urban Health, 83(6), 1132-1142.

Copenhaver, M., Johnson, B.T., Lee, I., Carey, M., & Harman, J. (2006). Behavioral HIV risk reduction among injection drug users: Meta-analytic evidence of efficacy. Journal of Substance Abuse Treatment, (31), 163-171.

Copenhaver, M., & Fisher, J. (2006). Experts outline ways to improve the decade-long U.S. trend of 40,000 new HIV infections per year. AIDS & Behavior. (published online 1/06).

Copenhaver, M., Margolin, A., Avants, K., & Warburton, L. (2003). Intervening effectively with drug abusers infected with HIV: Taking into account the potential for cognitive impairment. Journal of Psychoactive Drugs, 35(2), 209-218.

Margolin, A., Kantak, K., Copenhaver, M.M., Avants, K.(2003). A preliminary controlled investigation of magnesium L-aspartate hydrocholoride for illicit cocaine and opiate use in methadone-maintained patients. Journal of Addictive Diseases, 22(2), 49-62.

Copenhaver, M.M. (2000). Testing a social-cognitive model of intimate abusiveness among substance dependent males. American Journal of Drug and Alcohol Abuse, 26(4), 603-628.